Related Experiment Video
Updated: Dec 21, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Interfering with Nuclear Transport as a Means of Interrupting Transcription Factor Activity in Cancer
Aderonke F Ajayi-Smith1, Pauline J van der Watt1, Virna D Leaner1
1Division of Medical Biochemistry and Structural Biology, Department of Integrative Biomedical Sciences, SAMRC/UCT Gynaecological Cancer Research Centre, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa.
Abstract:
Transcription factors control numerous cellular processes, including proliferation, apoptosis, differentiation, and inflammation. Abnormal transcription factor activity has been implicated in a variety of diseases, especially cancer. The correct subcellular localization of transcription factors determines their activation status, implicating the nuclear transport receptors as key players in regulating transcription factor function. Dysregulation of the nuclear transport machinery has been described in numerous cancer types. This review summarizes how altered nuclear transport activity affects transcription factor localization and activity, and contributes to cancer development. Furthermore, the potential of targeting nuclear transporters for cancer therapy is discussed.
Insights
Transcription factors regulate cell functions, and their mislocalization due to nuclear transport issues drives cancer. Targeting nuclear transporters offers a promising therapeutic strategy for cancer treatment.
Area of Science:
- Molecular biology
- Cell biology
- Cancer research
Background:
- Transcription factors are crucial regulators of cellular processes like proliferation and apoptosis.
- Aberrant transcription factor activity is a hallmark of many diseases, particularly cancer.
- Subcellular localization dictates transcription factor activity, highlighting the role of nuclear transport.
Purpose of the Study:
- To review the impact of altered nuclear transport on transcription factor localization and activity in cancer.
- To discuss the potential of targeting nuclear transporters as a cancer therapy strategy.
Main Methods:
- Literature review of studies on transcription factors, nuclear transport, and cancer.
- Analysis of mechanisms linking nuclear transport dysregulation to cancer development.
- Evaluation of therapeutic strategies targeting nuclear transporters.
Main Results:
- Dysregulated nuclear transport machinery is frequently observed in various cancer types.
- Altered nuclear transport affects transcription factor localization, leading to aberrant cellular functions.
- Nuclear transport pathways are implicated in the progression and development of cancer.
Conclusions:
- Altered nuclear transport significantly contributes to cancer pathogenesis by affecting transcription factor activity.
- Targeting nuclear transport mechanisms presents a viable and promising avenue for novel cancer therapies.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Regulation of Nuclear Protein Sorting
Treatment Resistant Cancers
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...
Types of RNA
RNA Performs Diverse...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...